1. Home
  2. STEX vs RNXT Comparison

STEX vs RNXT Comparison

Compare STEX & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Streamex Corp.

STEX

Streamex Corp.

HOLD

Current Price

$0.63

Market Cap

73.5M

Sector

N/A

ML Signal

HOLD

Logo RenovoRx Inc.

RNXT

RenovoRx Inc.

HOLD

Current Price

$1.71

Market Cap

79.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STEX
RNXT
Founded
2009
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
73.5M
79.4M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
STEX
RNXT
Price
$0.63
$1.71
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$9.00
$8.25
AVG Volume (30 Days)
870.3K
1.4M
Earning Date
05-17-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
20.00
EPS
N/A
N/A
Revenue
$18,000.00
$1,123,000.00
Revenue This Year
N/A
$194.66
Revenue Next Year
$1,044.81
$279.78
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2511.63
52 Week Low
$0.57
$0.70
52 Week High
$7.19
$2.59

Technical Indicators

Market Signals
Indicator
STEX
RNXT
Relative Strength Index (RSI) 39.52 51.22
Support Level N/A $0.83
Resistance Level $1.07 $2.59
Average True Range (ATR) 0.05 0.26
MACD -0.01 -0.07
Stochastic Oscillator 23.69 13.46

Price Performance

Historical Comparison
STEX
RNXT

About STEX Streamex Corp.

Streamex Corp is a vertically integrated technology and infrastructure company. The Company is a technology company with two principal lines of business: (i) Tokenized Asset Finance, focused on digital asset and real-world asset tokenization via Streamex Exchange platform, and (ii) Biomedical Technology, focused on signal processing solutions in electrophysiology. The group provides institutional-grade solutions that bring traditional commodities and assets on-chain through secure, regulated, and yield-bearing financial instruments. It is committed to delivering transparent, scalable, and compliant digital asset solutions that bridge the gap between traditional finance and blockchain-enabled markets.

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Share on Social Networks: